Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Hertility Acquires Competitor Grip as the Two Female-founded Companies Join Forces in a United Goal to Revolutionise Women’s Health
Today, women’s health company Hertility is announcing the acquisition of Netherlands-based fertility and hormone testing […]
Vytal Announces the Appointment of Prasanna Parthasarathy as Chief Executive Officer
Vytal, a pharmacy service and healthcare technology company, today announced the appointment of Prasanna Parthasarathy as chief […]
Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer
Kineticos Life Sciences announced today that Thomas A. Pitler, Ph.D. has joined as President and Chief Operating […]
Inflect Health Expands its Strategic Partnership with GEn1E Lifesciences to Combat Rare & Inflammatory Diseases
Inflect Health, the innovation hub of Vituity, a physician-owned and operated partnership with 3500+ physicians across […]
ADA Names Charles D. Henderson as New Chief Executive Officer
The American Diabetes Association® (ADA), the nation’s leading voluntary health organization fighting to bend the curve […]
Roche Enters Partnership With the Global Fund to Support Low- and Middle-income Countries in Strengthening Critical Diagnostics Infrastructure
Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Global Fund […]
BICO Group Adds Senior Ir Manager to Its Executive Management
Åsa Hillsten has been appointed SVP and Head of IR at BICO and will be […]
Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as […]
Targovax Announces Clinical Collaboration With Agenus for Upcoming ONCOS-102 Phase 2 Melanoma Trial
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Engine, Bringing Enhanced and Unmatched Pharmacovigilance Capabilities to Life Sciences Industry
ArisGlobal, the global market leader in drug safety solutions worldwide, and Boehringer Ingelheim, a leading […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more